Uncovering the hidden socioeconomic impact of juvenile idiopathic arthritis and paving the way for other rare childhood diseases: an international, cross-disciplinary, patient-centered approach (PAVE Consortium)
Por:
Marshall DA, Gerber B, Currie GR, Anton-Lopez J, De Somer L, Dey M, Egert T, Egert Y, Henan L, Klotsche J, Martinez-Mifsut L, Minden K, Normand C, Porte D, Saurenmann RK, Swart JF, Uziel Y, Wilson J, Wouters C, Ziv A and Benseler SM
Publicada:
9 ago 2024
Ahead of Print:
9 ago 2024
Resumen:
BackgroundJuvenile idiopathic arthritis (JIA) refers to a heterogeneous
group of rheumatic conditions in children. Novel drugs have greatly
improved disease outcomes; however, outcomes are impacted by limited
awareness of the importance of early diagnosis and adequate treatment,
and by differences in access across health systems. As a result,
patients with JIA continue to be at risk for short- and long-term
morbidity, as well as impacts on virtually all aspects of life of the
child and family. Main bodyLiterature on the socioeconomic burden of JIA
is largely focused on healthcare costs, and the impact of JIA on
patients, families, and communities is not well understood. High quality
evidence on the impact of JIA is needed to ensure that patients are
receiving necessary support, timely diagnostics, and adequate treatment,
and to inform decision making and resource allocation. This commentary
introduces the European Joint Programme on Rare Diseases: Producing an
Arthritis Value Framework with Economic Evidence: Paving the Way for
Rare Childhood Diseases (PAVE) project, which will co-develop a
patient-informed value framework to measure the impact of JIA on
individuals and on society. With a patient-centered approach,
fundamental to PAVE is the involvement of three patient advocacy
organizations from Canada, Israel, and Europe, as active research
partners co-designing all project phases and ensuring robust patient and
family engagement. The framework will build on the findings of projects
from six countries: Canada, Germany, Switzerland, Spain, Israel, and
Belgium, exploring costs, outcomes (health, well-being), and unmet needs
(uveitis, mental health, equity). ConclusionThis unique international
collaboration will combine evidence on costs (from family to societal),
outcomes (clinical, patient and family outcomes), and unmet needs, to
co-design and build a framework with patients and families to capture
the full impact of JIA. The framework will support the development of
high-quality evidence, encompassing economic and clinical
considerations, unmet needs, and patient perspectives, to inform
equitable resource allocation, health system planning, and quality of
care better aligned with the needs of children with JIA, their families,
and communities. Knowledge gained from this novel approach may pave the
way forward to be applied more broadly to other rare childhood diseases.
Filiaciones:
Marshall DA:
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada
McCaig Institute for Bone and Joint Health, University of Calgary, Calgary, AB, Canada
O'Brien Institute for Public Health, University of Calgary, Calgary, AB, Canada
Gerber B:
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Currie GR:
Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada
Department of Pediatrics, University of Calgary, Calgary, AB, Canada
University of Calgary, Health Research Innovation Centre, Room 3C56, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada
Anton-Lopez J:
Study Group of Diseases Due to Immune Dysfunction in Pediatrics (GEMDIP), Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
Department of Surgery, Surgical Specialties and Pediatrics, Universitat de Barcelona, Barcelona, Spain
Department of Pediatric Rheumatology, Hospital Sant Joan de Déu, ERN RITA and ReCONNET Center, Esplugues de Llobregat, Barcelona, Spain
De Somer L:
Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium
Pediatric Rheumatology Leuven University Hospital, Leuven, Belgium
Dey M:
School of Health Science, Institute of Public Health, ZHAW Zurich University of Applied Sciences, Winterthur, Switzerland
Egert T:
INBAR - Israeli Arthritis Foundation, Ramat Gan, Israel
Egert Y:
INBAR - Israeli Arthritis Foundation, Ramat Gan, Israel
Henan L:
Meir Medical Center, Department of Pediatrics, Pediatric Rheumatology Unit, Kfar Saba, Israel
Klotsche J:
German Rheumatism Research Centre, Berlin, Germany
Martinez-Mifsut L:
Hospital Sant Joan de Déu, Patient Experience Area, Esplugues de Llobregat, Spain
Minden K:
German Rheumatism Research Centre, Berlin, Germany
Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany
Normand C:
European Network for Children With Arthritis and Autoinflammatory Diseases (ENCA), Gradignan, France
Porte D:
Cassie and Friends Society, Vancouver, Canada
Saurenmann RK:
Department of Pediatrics, Cantonal Hospital Winterthur, Brauerstr, Winterthur, Switzerland
Swart JF:
Department of Pediatric Immunology, Wilhelmina Children's Hospital / University Medical Center, Utrecht, The Netherlands
Faculty of Medicine, Utrecht University, Utrecht, The Netherlands
Uziel Y:
School of Medicine, Faculty of Medical and Health Sciences, Tel Aviv University, Tel Aviv, Israel
Department of Pediatrics, Meir Medical Center, Kfar Saba, Israel
Wilson J:
Cassie and Friends Society, Vancouver, Canada
Wouters C:
Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium
Pediatric Rheumatology Leuven University Hospital, Leuven, Belgium
Ziv A:
Meir Medical Center, Department of Pediatrics, Pediatric Rheumatology Unit, Kfar Saba, Israel
Benseler SM:
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB, Canada
Department of Pediatrics, University of Calgary, Calgary, AB, Canada
Alberta Health Services, Calgary, AB, Canada
Green Published, gold
|